Bristol-Myers Squibb

• Holds the exclusive license to develop, manufacture and commercialize the monoclonal

antibody treatment owned by Rockefeller University. 25

• Part of the COVID-19 Therapeutics Accelerator funded by the Bill & Melinda Gates

Foundation, Wellcome, and Mastercard to “accelerate treatments, vaccines, and diagnostics”.